Skip to main content
Access Resources

MJFF Publications

1911 - 1920 of 7461 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • OPEN
    Title: Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20210508
    Citation Count: 23
  • OPEN
    Title: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.2108489118
    Citation Count: 16
  • OPEN
    Title: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease
    Journal Name: Molecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/molecules26237360
    Citation Count: 14
  • OPEN
    Title: GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐Analysis
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13374
    Citation Count: 13
  • OPEN
    Title: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-27204-9
    Citation Count: 17
  • OPEN
    Title: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12505
    Citation Count: 4
  • RESTRICTED
    Title: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.be
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: How to Increase Diverse Representation in Parkinson's Disease Trials
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and Treatment
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.